drugset / Trial / NCT05169450

Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke

NCT05169450 ↗

Completed 998 enrolled Dongzhimen Hospital, Beijing
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized positived-controlled study of Diterpene Ginkgolides Meglumine Injection (DGMI) vs Ginaton in patients with ischemic stroke (IS) was conducted between7/2013 and 4/2014. The study was designed to test efficacy of DGMI for IS. Post hoc analysis of this trial was conducted to evaluate the efficacy of DGMI in elderly (aged≥65 years) IS patients.

Timeline

Start
2013-07-01
Primary completion
2014-04-01
Completion
2014-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diterpene ginkgolides meglumine injection Unknown 25 mg Intravenous
Comparator Ginaton Unknown 35 mg Intravenous
Comparator Ginaton Unknown 60 mg Intravenous